Showing 5981-5990 of 21466 results for "".
- Engineered Peptide Blocks Alpha-Synuclein Aggregation, Offering Hope for Parkinson’s Disease Therapieshttps://reachmd.com/news/engineered-peptide-blocks-alpha-synuclein-aggregation-offering-hope-for-parkinsons-disease-therapies/2483853/A team of UK researchers has designed a miniature, structurally stabilized peptide that potently inhibits the aggregation of alpha-synuclein (αS), the protein central to Parkinson’s disease and related s
- Latino Melanoma Patients Face Barriers to Early Diagnosis and Treatmenthttps://reachmd.com/news/latino-melanoma-patients-face-barriers-to-early-diagnosis-and-treatment/2483846/A new qualitative study published in JAMA Dermatology explored persistent disparities Latino patients face in timely melanoma diagnosis and treatment, despite advances in therapy that have improved survival among non-Hispani
- Percutaneous A1 Pulley Release: Faster Relief for Trigger Fingerhttps://reachmd.com/news/percutaneous-a1-pulley-release-faster-relief-for-trigger-finger/2483595/In treating trigger finger, percutaneous A1 pulley release is a commonly considered option alongside corticosteroid injection. In a randomized comparison of percutaneous release
- AI-Driven Smart Bandage Shows Promise in Accelerating Wound Healinghttps://reachmd.com/news/ai-driven-smart-bandage-shows-promise-in-accelerating-wound-healing/2483596/Scientists from the University of California and collaborating institutions have developed a-Heal—a closed-loop system that continuously monitors wound status, interprets healing stages using machine
- Enhancing Measurement Reliability in Radiology: The Role of Digital Morphometryhttps://reachmd.com/news/enhancing-measurement-reliability-in-radiology-the-role-of-interpreter-expertise/2483593/Radiologists are grappling with variability in image interpretations that is directly impacting patient outcomes. In one health system analysis, interpretations performed by nonphysician practitioners were associated
- LEO Pharma Finalizes Acquisition of Spevigo® for Rare Dermatologic Diseaseshttps://reachmd.com/news/leo-pharma-finalizes-acquisition-of-spevigo-for-rare-dermatologic-diseases/2483600/LEO Pharma has officially completed its acquisition of Spevigo® (spesolimab) from Boehringer Ingelheim, according to a press release from the manufacturer. The purchase represents the c
- FDA Approves Remibrutinib for Adults With CSUhttps://reachmd.com/news/fda-approves-remibrutinib-for-adults-with-csu/2483590/The US Food and Drug Administration (FDA) has approved remibrutinib (Rhapsido, Novartis) as the first oral Bruton’s tyrosine kinase (BTK) inhibitor for the treatment of chronic spontaneous urticaria (CSU) in adults whose symptoms persist despite H1 antihistamine the
- Preserving Vision in Aging: The Essential Roles of Regular Eye Examshttps://reachmd.com/news/preserving-vision-in-aging-the-essential-roles-of-regular-eye-exams-and-nutrition/2483582/Maintaining vision in aging adults is a continuous healthcare challenge, with the importance of proactive care growing as our population ages. In practice, many professional groups advise comprehensive eye examinations annually or every 1–2 years for older adults, underscoring the n
- Unveiling the Long-term Risks of Childhood Sunburns on Skin Cancer Developmenthttps://reachmd.com/news/unveiling-the-long-term-risks-of-childhood-sunburns-on-skin-cancer-development/2483584/The legacy of childhood sunburns continues to unfold across a lifetime, leaving indelible marks that heighten the risk of skin cancer, especially cSCC. Dermatologists and pediatricians must emphasize the lasting implications of UV damage witnessed in an era of growing skin cancer in
- Lung Cancer Treatment: Evaluating Surgery, Radiation, and Novel Therapieshttps://reachmd.com/news/lung-cancer-treatment-evaluating-surgery-radiation-and-novel-therapies/2483578/As lung cancer persists as a formidable adversary in oncology, the clinical landscape for Non-Small Cell Lung Cancer (NSCLC) treatment is rapidly evolving. With the rising prominence of stereotactic body radiation therapy (SBRT) for medically inoperable early-stage disease—as endors